H2 Protects Against Lipopolysaccharide-Induced Cardiac Dysfunction via Blocking TLR4-Mediated Cytokines Expression

Sihua Tan, Zhiyuan Long, Xiangping Hou, Yujie Lin, Jingting Xu, Xinchao You, Tinghuai Wang, Yaxing Zhang

Frontiers in Pharmacology · 2019 · 32 citations · 60 references

DOIFull text

Open access

Concepts

Abstract

Key Results: LPS induced cardiac dysfunction; hydrogen therapy improved cardiac function after LPS challenge. Furthermore, pretreatment with hydrogen resulted in cardioprotection during septic cardiomyopathy via inhibiting the expression of proinflammatory cytokines TNF, IL-1, and IL-18; suppressing the phosphorylation August 2019 | Volume 10 | Article 865 Frontiers in Pharmacology | www.frontiersin.org of ERK1/2, p38, and JNK; and reducing the nuclear translocation of NF-B and the expression of TLR4 by LPS.

References

60